Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Director departure
Appointed director
CC transcript

AMGEN INC (AMGN) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
10/06/2023 8-K Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation or an Obligation under an Off-B...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"AMGEN COMPLETES ACQUISITION OF HORIZON THERAPEUTICS PLC Advances Amgen's Mission to Serve Patients With First-in-Class Rare Disease Medicines"
10/05/2023 8-K Other Events  Interactive Data
09/27/2023 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
08/21/2023 3 Busch Matthew C. (VP, Finance & CAO) has filed a Form 3 on AMGEN INC
08/11/2023 4 Gordon Murdo (EVP, Global Commercial Ops) has filed a Form 4 on AMGEN INC
Txns: Sold 9,558 shares @ $262.43, valued at $2.5M
08/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/10/2023 144 Form 144 - Report of proposed sale of securities:
08/03/2023 8-K Quarterly results
Docs: "AMGEN REPORTS SECOND QUARTER FINANCIAL RESULTS"
07/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/23/2023 4 Williams R Sanders (Director) has filed a Form 4 on AMGEN INC
Txns: Granted 939 shares @ $0
05/23/2023 4 SUGAR RONALD D (Director) has filed a Form 4 on AMGEN INC
Txns: Granted 939 shares @ $0
05/23/2023 4 MILES AMY E (Director) has filed a Form 4 on AMGEN INC
Txns: Granted 939 shares @ $0
05/23/2023 4 Kullman Ellen Jamison (Director) has filed a Form 4 on AMGEN INC
Txns: Granted 939 shares @ $0
05/23/2023 4 Jacks Tyler (Director) has filed a Form 4 on AMGEN INC
Txns: Granted 939 shares @ $0
05/23/2023 4 ISHRAK OMAR (Director) has filed a Form 4 on AMGEN INC
Txns: Granted 939 shares @ $0
05/23/2023 4 HOLLEY CHARLES M (Director) has filed a Form 4 on AMGEN INC
Txns: Granted 939 shares @ $0
05/23/2023 4 Garland Greg C. (Director) has filed a Form 4 on AMGEN INC
Txns: Granted 939 shares @ $0
05/23/2023 4 ECKERT ROBERT (Director) has filed a Form 4 on AMGEN INC
Txns: Granted 939 shares @ $0
05/23/2023 4 Druker Brian (Director) has filed a Form 4 on AMGEN INC
Txns: Granted 939 shares @ $0
05/23/2023 4 Drake Michael V (Director) has filed a Form 4 on AMGEN INC
Txns: Granted 939 shares @ $0
05/23/2023 4 Austin Wanda M (Director) has filed a Form 4 on AMGEN INC
Txns: Granted 939 shares @ $0
05/18/2023 8-K Other Events  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
05/16/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"AMGEN RESPONDS TO FTC ACTION RE: PROPOSED ACQUISITION OF HORIZON THERAPEUTICS THOUSAND OAKS, Calif. - Amgen today issued the following statement in response to the U.S. Federal Trade Commission's complaint seeking to block the company's proposed acquisition of Horizon Therapeutics plc: “Amgen is disappointed by the FTC's decision and remains committed to completing this acquisition, which will bring significant benefits to patients suffering from very serious rare diseases in the U.S. and around the world. We have been working cooperatively over the past several months to address the questions raised by the FTC's investigative staff and believe we have overwhelmingly demonstrated that this combination poses no legitimate competitive issues. The medicines offered by Amgen and Horizon genera..."
05/09/2023 4 Santos Esteban (EVP, Operations) has filed a Form 4 on AMGEN INC
Txns: Paid exercise price by delivering 579 shares @ $231.89, valued at $134.3k
05/09/2023 4 REESE DAVID M (EVP, Research and Development) has filed a Form 4 on AMGEN INC
Txns: Paid exercise price by delivering 594 shares @ $231.89, valued at $137.7k
05/09/2023 4 Miller Derek (SVP, Human Resources) has filed a Form 4 on AMGEN INC
Txns: Paid exercise price by delivering 51 shares @ $231.89, valued at $11.8k
05/09/2023 4 Louie Linda H. (VP, Finance & CAO) has filed a Form 4 on AMGEN INC
Txns: Paid exercise price by delivering 16 shares @ $231.89, valued at $3.7k
05/09/2023 4 Khosla Rachna (SVP, Business Development) has filed a Form 4 on AMGEN INC
Txns: Paid exercise price by delivering 39 shares @ $231.89, valued at $9k
05/09/2023 4 Grygiel Nancy A. (SVP & CCO) has filed a Form 4 on AMGEN INC
Txns: Paid exercise price by delivering 54 shares @ $231.89, valued at $12.5k
05/09/2023 4 Griffith Peter H. (EVP & CFO) has filed a Form 4 on AMGEN INC
Txns: Paid exercise price by delivering 608 shares @ $231.89, valued at $141k
05/09/2023 4 Graham Jonathan P (EVP, Gen. Counsel & Secy.) has filed a Form 4 on AMGEN INC
Txns: Paid exercise price by delivering 592 shares @ $231.89, valued at $137.3k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy